Carolyn Oxencis, PharmD, BCPS, BCOP
Clinical Associate Professor, Department of Clinical Sciences
Locations
- MCW Pharmacy School
HRC H2600
Contact Information
Education
BA, Journalism and Mass Communication, University of Iowa College of Liberal Arts, Iowa City, IA
Post Graduate Year One (PGY-1) Pharmacy Practice Residency, Froedtert Hospital
Certifications
Board Certified Oncology Pharmacist (BCOP), Board of Pharmacy Specialties
Board Certified Pharmacotherapy Specialist (BCPS), Board of Pharmacy Specialties
Collaborative Institutional Training Initiative (CITI) Certification, Medical College of Wisconsin
Advanced Cardiac Life Support, American Heart Association
Immunization Certification, American Pharmacists Association
Biography
Research Interests
- Pharmacogenomics and precision medicine
- Direct oral anticoagulant use in cancer patients
- Cardiotoxicity of anticancer therapy
- Transitions of care
Publications
-
(Grahl J, Mills M, Singh A, Oxencis C, Mohr A, Mancuso T, Teng BQ, Bajorunaite R, Carver T, Peppard WJ.) Hosp Pharm. 2025 May 20:00185787251339360 PMID: 40406364 PMCID: PMC12092407 SCOPUS ID: 2-s2.0-105005872042 05/23/2025
-
Pharmacist perspectives on emerging T cell-engaging bispecific therapies in cancer therapeutics.
(Moore DC, Digiantonio N, Oxencis CJ, Taucher KD.) Am J Health Syst Pharm. 2024 Jul 08;81(14):574-582 PMID: 38394329 SCOPUS ID: 2-s2.0-85194354207 02/23/2024
-
New and emerging pharmacotherapies for the management of multiple myeloma.
(Moore DC, Oxencis CJ, Shank BR.) Am J Health Syst Pharm. 2022 Jul 08;79(14):1137-1145 PMID: 35333922 SCOPUS ID: 2-s2.0-85134360892 03/26/2022
-
ASHP Statement on the Pharmacist's Role in Clinical Pharmacogenomics.
(Haidar CE, Petry N, Oxencis C, Douglas JS, Hoffman JM.) Am J Health Syst Pharm. 2022 Apr 01;79(8):704-707 PMID: 34487145 SCOPUS ID: 2-s2.0-85128161244 09/07/2021
-
(Neuner J, Weil E, Fergestrom N, Stolley M, Kamaraju S, Oxencis C, Winn A, Laud PW, Flynn KE.) J Am Pharm Assoc (2003). 2022;62(4):1321-1328.e3 PMID: 35393248 SCOPUS ID: 2-s2.0-85127492109 04/09/2022
-
(Brown SA, Beavers C, Kamaraju S, Mohan M, Fatunde O, Echefu G, Zaharova S, Wallace B, Oxencis C.) Drug Metabolism Handbook Concepts and Applications in Cancer Research. 1 January 2022:967-992 SCOPUS ID: 2-s2.0-85148796959 01/01/2022
-
(Chakrabarti S, Wintheiser G, Tella SH, Oxencis C, Mahipal A.) Pharmacol Ther. 2021 Aug;224:107823 PMID: 33667525 SCOPUS ID: 2-s2.0-85102047484 03/06/2021
-
(Weil E, Zook F, Oxencis C, Canadeo A, Urmanski A, Waggoner M, Eastwood D, Pasquini M, Hamadani M, Hari P.) Biol Blood Marrow Transplant. 2017 Jun;23(6):952-957 PMID: 28288949 SCOPUS ID: 2-s2.0-85017516033 03/16/2017
-
(Weil E, Oxencis C.) Support Care Cancer. 2015 Aug;23(8):2507-13 PMID: 25971214 SCOPUS ID: 2-s2.0-84933182775 05/15/2015
-
(Murphy EM, Oxencis CJ, Klauck JA, Meyer DA, Zimmerman JM.) Am J Health Syst Pharm. 2009 Dec 01;66(23):2126-31 PMID: 19923314 SCOPUS ID: 2-s2.0-73649116397 11/20/2009
My goal as a clinical instructor is to help future pharmacists develop the skills necessary to take independent thinking and learning beyond the scope of the classroom, with exceptional patient care at the forefront of each learning experience. I embrace case-based teaching and active learning activities as they stimulate intellectual camaraderie and cooperative problem solving, and lay the groundwork for life-long collaborative interprofessional practice.
Carolyn Oxencis, PharmD, BCPS, BCOP